<DOC>
	<DOCNO>NCT01198626</DOCNO>
	<brief_summary>The purpose study determine efficacy , safety tolerability JNJ-32729463 compare moxifloxacin treatment subject require hospitalization Community-Acquired Bacterial Pneumonia ( CABP ) .</brief_summary>
	<brief_title>Efficacy Safety Study JNJ-32729463 Compared With Moxifloxacin Treatment Subjects Requiring Hospitalization Community-Acquired Bacterial Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>woman childbearing potential must agree use acceptable method birth control clinical diagnosis community acquire bacterial pneumonia ( CABP ) PORT score II great able generate adequate sputum specimen chest xray show presence new infiltrates lobar multilobar distribution characteristic bacterial pneumonia history tendon damage/disorders due quinolone therapy uncorrected hypokalemia history myasthenia gravis intubate time consent OR subject candidate enrollment openlabel S. aureus arm intubate great 12 hour prior randomization mild CABP PORT score less II viral , fungal , mycobacterial , atypical pneumonia primary diagnosis pneumonia suspect secondary aspiration primary , solitary lung abscess healthcareassociated pneumonia , hospitalacquired pneumonia , ventilatorassociated pneumonia know bronchial obstruction history postobstructive pneumonia . primary lung cancer another malignancy metastatic lung cystic fibrosis , know suspect Pneumocystis jiroveci ( carinii ) pneumonia , know suspect active tuberculosis infection necessitates use concomitant antibacterial agent addition study medication systemic antibiotic within last 96 hour randomization , exception hospitalize great 72 hour reason 30 day randomization ( exclude 24 hour period enrollment ) . history serious hypersensitivity reaction quinolone include moxifloxacin . female pregnant , breastfeeding , may pregnant . Other protocolspecific eligibility criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>community-acquired bacterial pneumonia</keyword>
	<keyword>CABP</keyword>
	<keyword>CAP</keyword>
	<keyword>pneumonia</keyword>
	<keyword>pneumonia , bacterial</keyword>
	<keyword>bacterial infection</keyword>
	<keyword>anti-bacterial agent</keyword>
	<keyword>anti-infective agent</keyword>
	<keyword>lung disease , interstitial</keyword>
	<keyword>respiratory tract disease</keyword>
	<keyword>respiratory tract infection</keyword>
	<keyword>community-acquired infection</keyword>
</DOC>